Today in Switzerland: A round-up of the latest news on Tuesday thelocal.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelocal.ch Daily Mail and Mail on Sunday newspapers.
Memo Therapeutics AG will receive CHF 10.5m (US $11.4m) from the Swiss government to clinically develop a SARS-CoV-2 antibody against COVID-19, allowing it to start Phase 1 studies in Q1, 2022.
Memo Therapeutics AG will receive CHF 10.5m (US $11.4m) from the Swiss government to clinically develop a SARS-CoV-2 antibody against COVID-19, allowing it to start Phase 1 studies in Q1, 2022.
Coulter Partners Recruits Chief Medical Officer for Memo Therapeutics huntscanlon.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from huntscanlon.com Daily Mail and Mail on Sunday newspapers.
BK Virus Infection Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.